heart failure and fatal arrhytmias sudden cardiac death
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: *Left ventricular dysfunction (LVEF *35%) due to prior MI (at least 40 days post MI) *Left ventricular dysfunction (LVEF *35%) due to non-ischemic heart disease *NYHA functional class II and III *Receiving chronic optimal medical therapy *Reasonable expectation of survival with a good functional status of more than 1 year
Exclusion criteria
Exclusion criteria: *pregnancy *Left ventricular ejection fraction >35% *NYHA functional class I and IV *Not receiving chronic optimal medical therapy *Expected survival less than 1 year
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint of the trial will be appropriate ICD discharge or anti-tachycardia pacing. | — |
Countries
Netherlands